Nye Ann Marie, Clinard Valerie B, Barnes Connie L
Department of Pharmacy Practice, Campbell University, Buies Creek, North Carolina and Department of Family Medicine, East Carolina University, Greenville, USA.
Consult Pharm. 2010 Feb;25(2):117-21. doi: 10.4140/TCP.n.2010.117.
Overactive bladder (OAB) is a common condition in the elderly. Treatments for OAB include nonpharmacological or behavioral therapy, pharmacological therapy, and surgical therapy. Antimuscarinic agents are the current pharmacological treatment for OAB and are known to cause memory impairment. A 66-year-old female presented with memory loss secondary to the administration of oxybutynin, which resulted in medication nonadherence. Upon review of her medications, the pharmacist recommended discontinuing the oxybutynin because of the anticholinergic effects on cognition. At a three-week follow-up visit, the patient reported an improvement in memory and medication adherence. Pharmacists can play a vital role in recognizing drug-induced side effects and educating patients in an effort to improve medication adherence.
膀胱过度活动症(OAB)在老年人中是一种常见病症。OAB的治疗方法包括非药物或行为疗法、药物疗法和手术疗法。抗毒蕈碱药物是目前治疗OAB的药物,已知会导致记忆障碍。一名66岁女性因服用奥昔布宁出现继发性记忆丧失,导致药物治疗依从性差。药师在复查其用药时,鉴于其对认知的抗胆碱能作用,建议停用奥昔布宁。在三周的随访中,患者报告记忆力和药物治疗依从性有所改善。药师在识别药物引起的副作用以及对患者进行教育以提高药物治疗依从性方面可发挥重要作用。